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Background: Many newly detected point mutations are located in protein-coding regions of the human genome.
Knowledge of their effects on the protein’s 3D structure provides insight into the protein’s mechanism, can aid the
design of further experiments, and eventually can lead to the development of new medicines and diagnostic tools.
Results: In this article we describe HOPE, a fully automatic program that analyzes the structural and functional
effects of point mutations. HOPE collects information from a wide range of information sources including
calculations on the 3D coordinates of the protein by using WHAT IF Web services, sequence annotations from the
UniProt database, and predictions by DAS services. Homology models are built with YASARA. Data is stored in a
database and used in a decision scheme to identify the effects of a mutation on the protein’s 3D structure and
function. HOPE builds a report with text, figures, and animations that is easy to use and understandable for (bio)
medical researchers.
Conclusions: We tested HOPE by comparing its output to the results of manually performed projects. In all
straightforward cases HOPE performed similar to a trained bioinformatician. The use of 3D structures helps
optimize the results in terms of reliability and details. HOPE’s results are easy to understand and are presented in a
way that is attractive for researchers without an extensive bioinformatics background.
Background
The omics-revolution has led to a rapid increase in
detected disease-related human mutations. A consider-
able fraction of these mutations is located in protein-
coding regions of the genome and thus can affect the
structure and function of that protein, thereby causing a
phenotypic effect. Knowledge of these structural and
functional effects can aid the design of further experi-
ments and can eventually lead to the development of
better disease diagnostics or even medicines to help
cure patients. The analysis of mutations that cause the
EEC syndrome, for example, revealed that some patients
carry a mutation that disturbs dimerisation of the
affected P63 protein [1]. This information has triggered
a search for drugs http://www.epistem.eu; [2]). In
another case, the study of a mutation in the human
hemochromatosis protein (HFE), which causes heredi-
tary hemochromatosis, resulted in new insights that are
now being used to develop novel diagnostic methods
[3]. These and numerous other examples have high-
lighted the importance of using heterogeneous data,
especially structure information, in the study of human
disease-linked protein variants.
The data that can aid our understanding of the under-
lying mechanism of disease related mutations can range
from the protein’s three-dimensional (3D) structure to
its role in biological pathways, or from information gen-
erated by mutagenesis experiments to predicted func-
tional motifs. Collecting all available information related
to the protein of interest can be challenging and time-
consuming. It is a difficult task to extract exactly those
pieces of information that can lead to a conclusion
about the effects of a mutation. Several online Web ser-
vers exist that offer help to the (bio)medical researcher
in predicting these effects. These servers use informa-
tion from a wide range of sources to reach conclusions
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server, for example, is widely used by researchers to pre-
dict the possible impact of an amino acid substitution
on the structure and function of human proteins [4].
PolyPhen combines a subset of the UniProt sequence
features, structural information (when available), and
multiple sequence alignments in order to draw conclu-
sions about the impact of a mutation [4]. SIFT, on the
other hand, bases its mutation analysis purely on a mul-
tiple sequence alignment [5]. This server gives probabil-
ity scores for each amino acid type at the position of
interest to separate the harmless mutations from dis-
ease-causing ones. The ALAMUT software http://www.
interactive-biosoftware.com/ is widely used in human
genetics research groups. It focuses on making many
forms of software and databases available to their users.
The ALAMUT system also automatically calls the Poly-
Phen Web server as part of its decision process. ALA-
MUT is not available as a Web server. PolyPhen, Sift
and Alamut all have an excellent track-record make
existing data accessible for (bio)medical scientist to aid
them with the interpretation of mutational effects. We
built on their strengths to produce the HOPE software
that was written to optimally use the advantages of the
novel tools of the e-Science era.
The recent increase in data types and data volumes
has gone hand-in-hand with large efforts in bioinfor-
matics that have led to numerous new databases and
computational methods, and in this era of e-Science,
Web services provide on-demand access to these facil-
ities [6-8]. The development of Web services facilitates
the usage of external databases and methods in in-house
developed software and eases software maintenance and
development by out-sourcing logic to Web services.
Web services have a series of advantages for the soft-
ware developers:
￿ They save time by reusing program code;
￿ They tend to always be up-to-date;
￿ They are executed remotely, which gives access to
large amounts of (free) CPU time, thus not overload-
ing the local machine;
￿ No need to maintain in-house data and software
collections.
Web services also have disadvantages:
￿ Source code of Web services often is not available;
￿ Web services are not guaranteed to always be
available.
HOPE (Have (y)Our Protein Explained) is a next-
generation web application for automatic mutant analy-
sis. We have designed HOPE to explain the molecular
origin of a disease related phenotype caused by mutations
in human proteins. In this aspect HOPE resembles the
aforementioned systems (PolyPhen, SIFT, ALAMUT).
With HOPE we have taken the logical next step in the e-
Science era in that the data gathering is done using Web
services and DAS servers. Additionally, in HOPE we have
taken a protein 3D structure centred approach. HOPE
collects information from data sources such as the pro-
tein’s 3D structure and the UniProt database of well-
annotated protein sequences. For each protein this data
is stored in a PostgreSQL-based information system.
A decision scheme is used to process these data and to
predict the effects of the mutation on the 3D structure
and the function of the protein. A life-scientist friendly
report is produced that explains and illustrates the effects
of the mutation. This report is presented using an inter-
face that is designed specifically for the intended user
community of human genetics researchers. The report is
enriched with figures that illustrate the effects of the
mutation, while any residual bioinformatics jargon is
linked to our in-house, online dictionary of bioinfor-
matics jargon. The conclusions drawn in the report can
be used to design follow-up experiments and eventually
can lead to the development of better diagnostics or even
medicines. Figure 1 illustrates the major steps of HOPE.
We have tested HOPE on a series of mutations that we
have previously analyzed manually. In all straightforward
cases HOPE performed equally well as a trained protein
structure bioinformatician.




The intended users of HOPE are life scientists who
neither routinely use protein structures nor bioinfor-
matics in their research. Therefore, both HOPE’si n p u t
and its results are designed to be intuitive and simple,
and all software used will run with default settings so
that the user neither needs to set parameters nor needs
to read documentation. Actually, the user will not even
know which software runs in the background. The inter-
face of HOPE is a website that enables the user to sub-
mit a sequence and a mutation. The user can indicate
the mutated residue and the new residue type by simple
mouse-clicks. Figure 2 shows the input screen, filled
with an example protein sequence and a mutation.
Information retrieval
HOPE uses the submitted sequence as query for BLAST
[9] searches against both the UniProt database [10] and
the Protein Data Bank [11]. The search against the Uni-
Prot database identifies the protein’sU n i P r o te n t r ya n d
the accession code of the protein, a unique identifier
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tions. Alternatively, it is possible to submit this acces-
sion code directly. The BLAST search against the PDB
is required to find the protein’s structure or a possible
template for homology modelling. HOPE uses the actual
PDB-file when it contains the residue that is to be
mutated and when it is 100% identical with the sub-
mitted sequence. HOPE identifies among multiple 100%
hits the best structure for analysis based on resolution,
experimental method, and length of the protein covered
in the PDB (a full protein is preferred over a fragment).
Nowadays, 20% of the human sequences available from
SwissProt have a (partly) known structure and for
another 30% a homology model can be build. To be
able to build a homology model, the BLAST results
should contain the equivalent location of the mutation
and the percentage sequence identity should fall above
the Sander and Schneider curve shown in Figure 3.
Homology modelling is performed using the Twinset
version of YASARA which contains an automatic
Figure 1 Overview of HOPE’sp r o c e s sf l o w . The user submits a sequence and a mutation. HOPE will first collect information from a wide
range of information sources. These sources include: WHAT IF for structural calculations on either the PDB file or a homology model that was
build by YASARA, HSSP for conservation scores, DAS-servers for sequence-based predictions and Uniprot for sequence annotations. The data is
stored in HOPE’s information system. The data is combined with the known properties of the amino acids in a decision schedule. The result is a
report shown on the HOPE website that will focus on the effect of the submitted mutation on the 3D-structure of the protein. The text and
figures can be used in articles and publications.
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as input [12]. The script fully automatically performs the
modelling process including sequence alignment, loop
building, side chain modelling, and energy minimization.
This script was the top contestant in the CASP8 model-
ling competition in terms of model detail accuracy [13].
The structure of the protein of interest, either a PDB-
file or a homology model, is analyzed using WHAT IF
Web services [7]. These services can calculate a wide
range of structural features (e.g. accessibility, hydrogen
bonds, salt bridges, ligand or ion interactions, mutability,
variability, etc). When neither a 3D structure nor a pos-
sible modelling template is available, HOPE cannot use
structural information and will instead base its conclu-
sions only on the sequence related data, and published
mutation and variation results.
The UniProt database http://www.uniprot.org/ is used
for the retrieval of features that can be mapped on the
sequence [14]. This information includes the location of
active sites, transmembrane domains, secondary struc-
ture, domains, motifs, experimental information, and
sequence variants. The UniProt accession code is used
to retrieve data from a series of DAS-servers for
sequence based predictions such as possible phosphory-
lation sites. The DAS-servers form a widely used system
for biological sequence annotation [15].
The conservation score of the mutated residue is cal-
culated from a HSSP multiple sequence alignment [16].
Data storage in HOPE
Information obtained from the protein structure or
model, the UniProt record, and the DAS-predictions is
Figure 2 HOPE’s input screen. The user can submit a sequence of interest and indicate the mutated residue with two simple mouse-clicks. In
this example HOPE will analyze a leucine to proline mutation on position 25 of the plant protein Crambin.
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the PostgreSQL database system. One new information
system is produced for each submitted protein. Differ-
ences in the protein sequence might exist between data
sources, for example sequences from UniProt often con-
tain the signal peptide while the sequences stored in the
PDB tend to lack these residues. Therefore, sequences
obtained from different sources are aligned using Clus-
talW. This enables us to transfer information to the
residue of interest without the need to deal with
the residue numbering problem that results from these
sequence differences. Protein features are stored in
the information system on a per-residue basis, and can
have one of the following four data-types:
￿ Contacts: Interaction of the residue with another
entity; for example DNA, a metal-ion, a ligand,
hydrogen bond, disulfide bond, salt bridge;
￿ Variable features: Type with a value: for example,
accessibility or torsion angle;
￿ Fixed features: Labels a residue (or stretch of resi-
dues) with a feature without a value. This indicates
that the residue is located in a domain or motif (for
example a residue can be part of the active site or in
a transmembrane region);
￿ Variants: Mutations or other variations in sequence
known at this position; for example splice variants,
mutagenesis sites, SNPs.
After a user request has triggered the generation of an
information system for the protein of interest, the sys-
tem for this protein is kept on disk for one month just
in case the same user (or another user for that matter)
requests information about other mutations in the same
molecule. After one month every system is thrown away
to ensure that conclusions are never based on outdated
information. So, there does not really exist a HOPE
database as all HOPE’s data is, in total agreement with
e-Science paradigms, scattered over the internet, and is
each time combined upon request.
Decision scheme
The decision scheme in HOPE uses all collected infor-
mation combined with known properties of the wild-
type and mutated amino acid, such as size, charge, and
hydrophobicity, to predict the effect of the mutation on
the protein’s structure and function. The scheme con-
sists of six parts that each correspond to a paragraph in
the output. Each part analyzes the effect of the mutation
on one of the following aspects of the residue:
￿ Contacts. Any interaction with other molecules or
atoms, like DNA, ligands, metals, etc, but also
hydrogen bonds, disulfide bridges, ionic interactions,
etc;
￿ Structural domain. Any part of the protein with a
specific name (and often function), such as domains,
motifs, regions, transmembrane domains, repeats,
zinc fingers, etc;
￿ Modifications. Features that do not directly influ-
ence the structure of the protein but might influence
post-translational processes like phosphorylation.
￿ Variants. Known polymorphisms, mutagenesis
sites, splice variants, etc;
￿ Conservation: The relative frequency of an amino
acid type at each position taken from a multiple
sequence alignment.
￿ Amino acid properties: The differences in the
known properties of the wild-type and mutant resi-
due (size, charge, hydrophobicity).
HOPE will produce its conclusions for each of these
six aspects separately. For example, a residue can be
located in a transmembrane domain and also be impor-
tant for ligand interaction. HOPE will in this case pro-
duce a paragraph about the effect of the mutation on
the contacts and a separate paragraph describing the
effect of the mutation on the structural location, in this
example the transmembrane domain.
Figure 3 The two zones of sequence alignment identity that
indicate the likelihood of adopting similar structures. Two
aligned sequences are highly likely to have similar folds if their
length and percentage sequence identity fall in the region above
the threshold (black line). HOPE will build a homology model when
the identity between the template and submitted sequence falls in
this zone. In case the sequence identity is less than 5% above this
threshold (grey line) HOPE will build a model but will also warn that
the model is based on a template with low identity. The region
below the threshold (indicated with a cross) indicates the zone
where inference of structural similarity cannot be made, thus
making it difficult to determine if model building will be possible.
(Figure free after Sander and Schneider [25]).
Venselaar et al. BMC Bioinformatics 2010, 11:548
http://www.biomedcentral.com/1471-2105/11/548
Page 5 of 10Some types of information can be obtained from multi-
ple sources, which are not equally reliable. Experimen-
tally determined features and calculations performed on
the 3D coordinates are more likely to be correct than any
prediction. For example, transmembrane domains can be
predicted by a DAS-server which normally will produce
less reliable results than the annotations in UniProt.
Therefore, HOPE ranks the information and uses the
most accurate source available for its conclusions.
WHAT IF calculations are preferred, followed by UniProt
annotations, and DAS predictions are used only when
neither WHAT IF nor UniProt data are available. In case
no information about the mutated residue is found,
HOPE will show a conclusion based only on biophysical
characteristics between the wild type and mutant amino
acid type. The conservation score is obtained either from
the HSSP database that holds multiple sequence align-
ments for all proteins in the PDB, or through the HSSP
Web services if a PDB file is not available [16].
Output
The report focuses on the effect of the mutation on the
3D-structure, and is aimed at a specific audience in the
field of (bio)medical science. It shows the methods used
and the sources of the combined information. This can
either be an analysis of the real structure or homology
model, or a prediction based on the sequence. The
results of the mutation analyses are illustrated with fig-
ures of the amino acids and, if available, figures and ani-
mations of the mutation in the structure. The HOPE
output is rather extensive and way too large to put in
print, in Figure 4 we just show a small part of one
mutation report. A series of examples of HOPE output
is available at the “about” section of the HOPE pages.
A HOPE result consists of one HTML page that con-
tains all results. This makes it easy for users to print the
results, or to make their own Web-page with HOPE
results for long-term storage.
Test cases
HOPE was validated in a series of collaborations with
scientists from different fields of life sciences. Experi-
ences from these real-world examples where used to
design and adjust the decision scheme. So far, most
mutation studies involved non-sense and missense
mutations. Descriptions of these projects can be found
at the HOPE website. The resulting reports often con-
tain a molecular explanation of the observed phenotype
that can suggest further experiments. The majority of
these projects included the building of a homology
model as in most cases no 3D-structure of the protein
of interest was available.
We also validated HOPE’s conclusions by comparing
them with the output of PolyPhen and SIFT. Even
though it is very difficult to compare the results from
PolyPhen, SIFT, and HOPE, we can still draw a few gen-
eral conclusions, that will be elaborated on in the fol-
lowing paragraphs.
Structure adds value
The use of a protein’s 3D-structure or homology model
increases the prediction quality in terms of reliability
and detail. The possibility offered by the YASARA soft-
ware to fully automatically build high quality homology
models increases the number of sequences for which
HOPE can use structure data. The protein structure,
either a PDB-file or a homology model, can reveal infor-
mation that currently cannot be predicted accurately
from sequence alone, such as ionic interactions, ligand-
contacts, etc.
The value of the extra information that HOPE can
extract from a protein’s structure or model is illustrated,
for example, by the L320P and L347P mutations in
ESRBB (see the “about” section of the HOPE website).
All Web servers correctly predict the effect of these
mutations as damaging for the protein. However, HOPE
completes the story by an extensive explanation of the
disturbing effect of prolines on alpha-helices. In cases
for which no 3D structure data is available, the three
Web servers seem to perform similarly albeit that Poly-
phen’s output often tends to be scarce and a bit cryptic
and SIFT’s output is limited to conservation scores.
Biomedicist understandable results
HOPE’s interface was designed especially for users that
work in the (bio)medical sciences. Instead of displaying
data in the form of detailed tables and numerical values,
HOPE writes human readable reports that explain the
structural and functional effects of the mutation, and
illustrates this with figures and animations. When other
Web servers list the effects of a mutation as “Hydropho-
bicity change at buried site; normed accessibility: 0.00,
hydrophobicity change: -2.7”. HOPE will instead report
that “the mutation introduces a less hydrophobic residue
in the core of the protein which can destabilize the struc-
ture”. Many more examples of HOPE’s readable output
can be found at the “about” section of the HOPE web-
site. HOPE’s comprehensibility is improved by the Help-
function that links difficult bioinformatics keywords to
our own in-house dictionary based on Wikipedia’ss o f t -
ware. In this dictionary the user can find text, illustra-
tions, and sometimes a short video-clip that explains the
keyword.
Conclusions
Upon running 24 test cases, listed on the website, we rea-
lised that the present version of HOPE is useful and reli-
able in analysing point mutations. The next generation of
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integration to address more complicated cases. Some
answer might be found only by combining the calcula-
tions with literature data and general knowledge of the
protein’s structure function relations. For example, Poly-
Phen predicts the N255D mutation in Kv1.1 (discussed
in [17]) as being benign, while SIFT shows that this resi-
due is 100% conserved. Combination of the conservation
information with the fact that this residue is located in
the voltage sensor of the channel can result in the
hypothesis that the mutation disturbs the channel’sv o l -
tage sensing mechanism. Such conclusions are still
beyond the capabilities of today’s Web servers, but the
software design of HOPE will one day allow us to intro-
duce the features needed to deal which these more com-
plicated cases.
HOPE is an example of the new way of doing data-
and software-intensive research in the era of eScience.
Nowadays, the ongoing developments in experimental
techniques like high-throughput sequencing will
Figure 4 Example of HOPE’so u t p u t . A simplified example of HOPE’s output. A) Explanation of the used method (structure, modelling or
predictions) and links to the relevant databases. B) Text and pictures that explain the differences between the wild-type and mutant residue.
(Text is left out of this figure for clarity.) C) Paragraph of the report explaining the effect of the mutation on contacts made by the residue, a
disulfid bond in this case. It contains a link to the wiki-entry “cysteine” and “disulfid bond”. D) Images/animations that show the effect of the
mutation on the structure.
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therefore demand new, further automated approaches
towards the analysis of these data. The eScience
approach used will allow us to easily extend HOPE with
more Web services, data sources, and DAS predictions
when these become available. In the years to come
HOPE can be extended with the possibility to analyze
double-mutants, to quantitatively score the structural
effects of the mutation and thereby provide the possibi-
lity to automatically rank candidate mutations that are
the result of a sequence project, or to further improve
the already user-friendly HOPE user interface.
Methods
The HOPE system is schematically shown in Figure 5.
The individual elements of his schema are described in
the remainder of this section.
The HOPE website is implemented using the Wicket
http://wicket.apache.org/ web framework, which allows
us to provide a fluent and responsive user experience.
The web application is deployed on the GlassFish web
application container https://glassfish.dev.java.net/.
HOPE obtains information from different sources
beyond our control. Therefore, the data gathering is set
up as fail-safe as possible to handle service unavailabil-
ity. Data is cached to speed up the process, reduce
dependencies and to put less strain on external
resources. The data-retention time is 30 days, after
which time the data is renewed at the moment someone
runs an analysis on the same sequence. The database
scheme (available at the “about” section of the HOPE
pages) is the result of an iterative design process using
both Java and Hibernate to manage all data and to cre-
ate the database tables. The database engine is Post-
greSQL version 8.4.
The MRS BLAST version 4 Web service is used for
most database searches with an e-value cut-off of 1e-5
and the low-complexity filter switched off [18].
Figure 5 Detailed overview of HOPE’s components.H O P E ’s input consists of the sequence and the mutation. The sequence is used for a
BLAST search against the databases. Using the accession code (and PDB-file if available) HOPE can collect information from a series of
information sources: WHAT IF calculations on the PDB-file or homology model built by YASARA, annotations in the Uniprot database, HSSP
conservation scores and sequence-based predictions by DAS-servers. The information is combined in a decision scheme and a report is
generated. This report is illustrated with pictures and animations and difficult keywords are linked to our own online dictionary.
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is backed by an in-house implementation of the stan-
dard BLAST algorithm. ClustalW version 2.0.10 is used
for sequence alignments [19]. ClustalW is also offered
as a Web service through MRS http://mrs.cmbi.ru.nl/
mrsws/clustal/wsdl.
WHAT IF Web services, accessible via http://wiws.
cmbi.ru.nl/wsdl/, are used to calculate secondary struc-
ture (using DSSP [20]), accessibility values, structural
fits of mutations, contacts with ligands or ions, salt
bridges, disulfide bridges, and hydrogen bonds [21].
These calculations are performed either on the depos-
ited PDB structure, or a homology model. Homology
modelling is performed fully automatically using a
locally installed WHAT IF & YASARA Twinset [12,13].
This installation runs on a separate server, and is con-
trolled through a Perl CGI script.
Sequence annotations are obtained from the UniProt
database http://www.uniprot.org/[14] XML records. The
obtained information includes sequence features such as
active site, motifs, domains, variants and binding sites.
Conservation scores are obtained from HSSP using the
Web service for which the WSDL is available at http://
mrs.cmbi.ru.nl/hsspsoap/wsdl. When a PDB deposited
structure is available, the pre-calculated HSSP scores
maintained at the CMBI are used. In case a homology
model is available a DSSP file is generated for the
homology model, which in turn is used to create a
HSSP file. In case no structure or model is available, a
HSSP file is generated using only the user sequence.
Distributed Annotation (DAS) servers [15,22] are used
to obtain predictions regarding transmembrane regions
by Phobius [23], accessibilities by PHDacc [24], second-
ary structure by PHDsec [24], and phosphorylation sites
by NetPhos [22].
The decision scheme is implemented in Groovy, a
dynamic language that runs on the Java Virtual
Machine http://groovy.codehaus.org/. The simple
Groovy language enables other users to design their
own decision schemes and run a specific version of
HOPE for their own purposes. The decision scheme is
divided into separate branches targeted towards certain
aspects of the mutant analysis, each producing a para-
graph or sub-report. The decision scheme logic is sepa-
rated from the phrases used to compose the report, for
a cleaner separation in code and to allow for
internationalization.
The HOPE report is presented on a self-contained
webpage, allowing the user to save the page without
breaking links and images. The user can bookmark the
URL to perform the same mutant analysis at a later
point in time, incorporating any newly available data.
The output web pages are intended to be free from
bioinformatics jargon. An online dictionary based on
MediaWiki’s software http://www.mediawiki.org/ is used
to explain bioinformatics-specific terms. JavaScript is
used to link keywords on the webpage to articles present
in the local MediaWiki instance. This functionality is
available at any time via the omni-present blue help-
button. Images and movies in the report are generated
using the YASARA & WHAT IF Twinset.
Availability and Requirements
The full description of the design and implementation of
the HOPE server is available from the “about” section of
the HOPE pages. HOPE can be used freely and no
licenses are required. The source code has been made
open source and can be freely obtained from the HOPE
website. HOPE uses Java, Groovy, and PostgreSQL; it
has been implemented on a Linux system while care has
been taken to avoid system dependencies.
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